Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort. - Trottier B; Yang CJ; Watanabe D; Marchetti G; Elbirt D; De Barra E; Gündüz A; Lee SH; Vogelmann R; Robineau O; Choy CY; Berrevoets M; et al. (HIV research & clinical practice, 2025)